Literature DB >> 8048780

Dietary treatment of lymphedema by restriction of long-chain triglycerides.

P Soria1, A Cuesta, H Romero, F J Martínez, A Sastre.   

Abstract

Two patients suffering from idiopathic unilateral lower limb lymphedema were treated with a diet in which long-chain triglycerides (LCT) were drastically restricted. From the beginning of the treatment, a distinct improvement was observed in both patients, with reduction of the affected limb perimeters, decrease of edema tension, and decrease of skin turgescence. Patient A underwent weight loss, and the reduction of the diameter of the affected limb was greater than that in the nonaffected limb. In patient B, whose weight remained stable during the study, the diameter of the affected limb underwent a remarkable diminution, while no changes were detected in the nonaffected limb. To the authors' knowledge, this is the first report of dietary treatment of idiopathic lymphedema, these being preliminary results of an ongoing study in a group of patients suffering from lymphedema treated with a low LCT diet.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8048780     DOI: 10.1177/000331979404500805

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  3 in total

1.  Postprandial lymphatic pump function after a high-fat meal: a characterization of contractility, flow, and viscosity.

Authors:  Timothy Kassis; Sri Charan Yarlagadda; Alison B Kohan; Patrick Tso; Victor Breedveld; J Brandon Dixon
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-03-11       Impact factor: 4.052

2.  Risk of secondary lymphedema in breast cancer survivors is related to serum phospholipid fatty acid desaturation.

Authors:  Eunjung Ryu; Seung Yun Yim; Hyun Ju Do; Jae-Young Lim; Eun Joo Yang; Min-Jeong Shin; Seung-Min Lee
Journal:  Support Care Cancer       Date:  2016-04-04       Impact factor: 3.603

3.  Visual analysis of global research output of lymphedema based on bibliometrics.

Authors:  Yun-Dong Zhang; Xue Zhang; Xin-Yu Wang; Dong-Mei Han; Jian-Shi Du
Journal:  Front Oncol       Date:  2022-08-05       Impact factor: 5.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.